Pharmacists in Silverton, Oregon


12 Pharmacists found in Silverton
female pharmacist

Amber Renee Grant, RPH


Pharmacist
302 N First St, Silverton, OR 97381
503-873-6321     503-874-9811

female pharmacist

Dr. Baylee Mayfield, PHARMD


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
302 N 1st St, Silverton, OR 97381
503-873-6321     503-386-2514

female pharmacist

Brandie Mendoza


Pharmacist
406 Mcclaine St, Silverton, OR 97381
503-873-8392    



female pharmacist

Heather Erin Brown, RPH


Pharmacist
406 Mcclaine St, Silverton, OR 97381
503-873-8391     360-213-2238

female pharmacist

Jennifer Lynne Ellis


Pharmacist
333 Westfield St, Silverton, OR 97381
505-873-2460     503-873-4747

female pharmacist

Jennifer Johnson Gardner, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
11665 Hazelgreen Rd Ne, Silverton, OR 97381
541-510-4158    

male pharmacist

Mr. John Zahler, RPH


Pharmacist
342 Fairview St, Silverton, OR 97381
503-873-1573    

female pharmacist

Kathleen May Van Handel


Pharmacist
342 Fairview St, Silverton, OR 97381
503-873-1569    

male pharmacist

Kevin Knutson


Pharmacist
406 Mcclaine St, Silverton, OR 97381
503-873-8391    

female pharmacist

Kristi Lee Veis, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
406 Mcclaine St, Silverton, OR 97381
503-873-8391     360-213-2238

female pharmacist

Laikana Ly, PHARMD



335 Fairview St, Silverton, OR 97381
503-874-5625    

female pharmacist

Miranda Lynn Watzig, PHARMD


Pharmacist
406 Mcclaine St, Silverton, OR 97381
503-873-8391    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.